Article references (17 references )


  1. World Health Organization(WHO). Varicella and herpes zoster vaccines: WHO position paper. Wkly Epidemiol Rec. 2014;89(25):265-288. PubMed | Google Scholar

  2. EPilly, Collège des universitaires de maladies infectieuses et tropicales. Maladies infectieuses et tropicales. Paris: Alinéa Plus et CMIT. 2015.

  3. Ministère de la santé. Annuaire statistique 2015. Ouagadougou: DGESS. 2016.

  4. Ouhoummane N, Bouliane N, De Serres G, De Wals P, Besson M. Fardeau de la varicelle et du zona au Québec, 1990-2008: impact du programme de vaccination. Québec : Institut national de santé publique du Québec. 2011.

  5. Société de pathologie infectieuse de langue française (SPILF). 11èmeconférence de consensus en thérapeutique anti-infectieuse : prise en charge des infections à VZV. Méd Mal Infect. 1998 ; 28 :1-8.

  6. Groupe de travail du Comité Technique des Vaccinations. Recommandations vaccinales concernant la varicelle. France: Ministère de la santé, de la jeunesse et des sports. 2007. Google Scholar

  7. Blumental S, Sabbe M, Lepage P. Varicella paediatric hospitalisations in Belgium: a 1-year national survey. Arch Dis Child. 2016; 101(1):16-22. PubMed | Google Scholar

  8. Hobbelen PHF, Stowe J, Amirthalingam G, Miller L, van Hoek A-J. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013. Journal of Infection. 2016; 73(3) :241-253. PubMed | Google Scholar

  9. Grimprel E, Levy C, Rocque FDL, Cohen R, Soubeyrand B, Caulin E et al. Paediatric varicella hospitalisations in France: a nationwide survey. CMI. 2007; 13(5):546-549. PubMed | Google Scholar

  10. National Advisory Committee on Immunization (NACI). An Advisory Committee Statement (ACS): varicella proof of immunity-2015 Update. Canada: Public Health Agency of Canada. 2016.

  11. Hussey HS, Abdullahi LH, Collins JE, Muloiwa R, Hussey GD, Kagina BM. Varicella zoster virus-associated morbidity and mortality in Africa: a systematic review protocol. BMJ Open. 2016;6(4):e010213. PubMed | Google Scholar

  12. World Health Organization. Varicella vaccines: WHO position paper. Wkly Epidemiol Rec. 1998; 73(32):241-248. PubMed | Google Scholar

  13. Bollaerts K, Riera-Montes M, Heininger U, Hens N, Souverain A, Verstraeten T, Hartwig S. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiology and Infection. 2017; 145(13) :2666-2677. PubMed | Google Scholar

  14. Wateba MI, Saka B, Tidjani O. Aspects épidémiologiques, cliniques et thérapeutiques des varicelles graves de l'adulte et de l'enfant au CHU Sylvanus Olympio de Lomé, Togo. J Rech Sci Univ. 2014; 16(1):139-144. Google Scholar

  15. Pierik JG, Gumbs PD, Fortanier SA, Van Steenwijk PC, Postma MJ. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect Dis. 2012; 12:110. PubMed | Google Scholar

  16. VIDAL. Monographies pour Android. 2012.

  17. Belay ED, Shahriari A. Reye's Syndrome in the United States from 1981 through 1997. N Engl J Med. 1999; 340(18):1377-1382. PubMed | Google Scholar